NURECO (0793.640.439): financials and annual accounts

NURECO

Antwerp ·KBO/BCE: BE 0793.640.439

Line	2025	2024	2023	2022
Balance sheet: assets
`20/58`	54,834	78,040	50,030	14,196
`21/28`	1,470	2,146	2,821	-
`22/27`	970	1,646	2,321	-
`24`	970	1,646	2,321	-
`28`	500	500	500	-
`29/58`	53,364	75,894	47,209	14,196
`29`	10,000	10,000	10,000	-
`290`	0	10,000	10,000	-
`291`	10,000	-	-	-
`40/41`	7,462	26,599	22,889	13,013
`40`	4,500	10,475	13,569	12,342
`41`	2,962	16,124	9,320	671
`50/53`	7,500	1,500	-	-
`54/58`	27,416	36,992	14,049	1,183
`490/1`	986	804	271	-
Balance sheet: equity and liabilities
`10/49`	54,834	78,040	50,030	14,196
`10/15`	45,889	63,118	31,677	10,727
`10/11`	5,000	5,000	5,000	5,000
`13`	40,889	58,118	26,677	5,727
`133`	40,889	58,118	26,677	5,727
`14`	0	-	-	-
`17/49`	8,945	14,922	18,354	3,469
`42/48`	8,945	14,922	18,354	3,469
`43`	703	90	128	-
`430/8`	0	90	128	-
`439`	703	-	-	-
`44`	265	509	1,785	447
`440/4`	265	509	1,785	447
`45`	7,977	14,324	16,440	3,023
`450/3`	7,977	14,324	16,440	3,023
Income statement
`9900`	51,884	40,240	29,868	7,600
`630`	676	676	381	-
`640/8`	778	387	309	439
`9901`	50,431	39,178	29,177	7,162
`75/76B`	1,187	804	271	-
`75`	1,187	804	271	-
`65/66B`	68	69	68	3
`65`	68	69	68	3
`9903`	51,551	39,913	29,380	7,158
`67/77`	10,780	8,472	8,430	1,432
`9904`	40,771	31,441	20,950	5,727
`9905`	40,771	31,441	20,950	5,727
Appropriation of the result
`9906`	40,771	31,441	20,950	5,727
`791/2`	58,000	-	-	-
`691/2`	40,771	31,441	20,950	5,727
`6921`	40,771	31,441	20,950	5,727
`694/7`	58,000	-	-	-
`694`	58,000	-	-	-
Document	PDF	PDF	PDF	PDF

Financial year	Type	Filed	Reference	Document
31-12-2025	micro format	14-09-2026	2026-00512122	PDF
31-12-2024	micro format	12-08-2025	2025-00370722	PDF
31-12-2023	micro format	24-07-2024	2024-00277218	PDF
31-12-2022	micro format	26-07-2023	2023-00275261	PDF

2025	2024	2023	2022
51,107	39,853	29,559	-
41,447	32,117	21,331	-
0	0	3,202	-
-9,576	22,943	12,866	-
44,419	60,972	28,856	10,727
83.7%	80.9%	63.3%	75.6%
5.97	5.09	2.57	4.09
0.19	0.24	0.58	0.32
88.8%	49.8%	66.1%	53.4%
74.4%	40.3%	41.9%	40.3%
over 100	over 100	over 100	-

NURECO